0R15 8884.0068 1.4156% 0R1E 9171.0 0.0% 0M69 None None% 0R2V 255.5 0.0% 0QYR 1619.0 0.0% 0QYP 434.5 0.0% 0RUK None None% 0RYA 1606.0 4.9673% 0RIH 195.2 1.3763% 0RIH 195.2 0.0% 0R1O 225.5 9900.0% 0R1O None None% 0QFP None None% 0M2Z 255.0 0.2457% 0VSO 33.3 -6.4738% 0R1I None None% 0QZI 604.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 246.8 2.9706%
Last update at 2024-12-24T13:34:00Z
Seeing Machines to highlight advantages of camera-based driver monitoring at InCabin in Brussels
Thu 15 Jun 23, 06:00 AMWhen Can We Expect A Profit From Seeing Machines Limited (LON:SEE)?
Mon 12 Jun 23, 06:00 AMIs Seeing Machines Limited (LON:SEE) Trading At A 43% Discount?
Mon 15 May 23, 02:44 PMMarket Participants Recognise Seeing Machines Limited's (LON:SEE) Revenues
Mon 17 Apr 23, 09:43 AMSeeing Machines First Half 2023 Earnings: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022)
Wed 08 Mar 23, 05:31 AMStephen Copulos Just Bought 28% More Shares In Galilee Energy Limited (ASX:GLL)
Fri 29 Apr 22, 09:01 PMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | -15.57900M | -25.28700M | -16.68300M | -45.46400M | -41.74898M |
Minority interest | - | - | - | - | - |
Net income | -15.54800M | -25.32300M | -17.42000M | -46.71000M | -41.79494M |
Selling general administrative | 12.94M | 15.49M | 14.59M | 6.56M | 9.01M |
Selling and marketing expenses | 6.48M | 9.07M | 6.09M | 6.56M | 9.01M |
Gross profit | 28.90M | 24.41M | 20.77M | 14.43M | 18.73M |
Reconciled depreciation | - | - | - | - | - |
Ebit | -13.69900M | -26.79000M | -16.16500M | -44.75900M | -41.48412M |
Ebitda | -13.00800M | -24.83400M | -16.17000M | -44.68700M | -41.52361M |
Depreciation and amortization | 0.69M | 1.96M | -0.00500M | 0.07M | -0.03949M |
Non operating income net other | - | - | - | - | - |
Operating income | -13.69900M | -26.79000M | -16.17000M | -44.68700M | -41.48412M |
Other operating expenses | 72.39M | 81.22M | 63.24M | 85.15M | 74.37M |
Interest expense | 2.57M | 0.45M | 0.52M | 0.70M | 0.26M |
Tax provision | -0.03100M | 0.04M | 0.74M | 1.25M | 0.05M |
Interest income | 0.69M | 0.39M | 0.32M | 0.83M | 0.78M |
Net interest income | -1.88000M | -0.06100M | -0.19600M | 0.12M | 0.51M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -0.03100M | 0.04M | 0.74M | 1.25M | 0.05M |
Total revenue | 57.77M | 54.44M | 47.17M | 40.01M | 31.89M |
Total operating expenses | 43.51M | 51.20M | 36.84M | 59.57M | 61.21M |
Cost of revenue | 28.87M | 30.02M | 26.40M | 25.58M | 13.16M |
Total other income expense net | -1.88000M | 1.50M | -0.51300M | -0.77700M | -0.26486M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -15.54800M | -25.32300M | -17.42000M | -46.71000M | -41.79494M |
Net income applicable to common shares | -15.54800M | -25.32300M | -17.42000M | -46.71000M | -42.00600M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Total assets | 133.09M | 137.89M | 92.93M | 65.69M | 98.73M |
Intangible assets | 45.06M | 34.28M | 9.54M | 0.90M | 2.54M |
Earning assets | - | - | - | - | - |
Other current assets | 1.12M | 8.24M | 5.44M | 4.23M | 4.76M |
Total liab | 66.56M | 30.77M | 20.89M | 19.49M | 10.65M |
Total stockholder equity | 66.53M | 107.12M | 72.05M | 46.20M | 88.08M |
Deferred long term liab | 47.08M | 33.97M | 8.31M | - | 1.46M |
Other current liab | 9.05M | 8.72M | 5.67M | 1.06M | 0.29M |
Common stock | 240.95M | 313.03M | 257.38M | 217.20M | 217.20M |
Capital stock | 240.95M | 313.03M | 257.38M | 217.20M | 217.20M |
Retained earnings | -185.52000M | -227.36900M | -202.04600M | -184.63800M | -137.32773M |
Other liab | 2.64M | 0.36M | 0.19M | 0.21M | 0.21M |
Good will | - | - | - | - | - |
Other assets | 47.08M | 33.97M | 8.31M | - | 1.46M |
Cash | 36.14M | 58.76M | 47.39M | 38.14M | 54.81M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 21.40M | 26.06M | 15.42M | 13.51M | 8.84M |
Current deferred revenue | - | - | - | 3.52M | 4.41M |
Net debt | 7.09M | -53.45200M | -41.20300M | -31.31500M | -53.67545M |
Short term debt | 0.71M | 0.95M | 0.92M | 1.06M | 0.52M |
Short long term debt | - | - | - | 0.16M | 0.36M |
Short long term debt total | 43.23M | 5.30M | 6.19M | 6.82M | 1.13M |
Other stockholder equity | 11.10M | 21.46M | 16.71M | 13.63M | 8.20M |
Property plant equipment | 5.71M | 7.85M | 7.61M | 7.58M | 8.09M |
Total current assets | 82.31M | 95.76M | 75.78M | 57.21M | 93.01M |
Long term investments | - | - | - | - | - |
Net tangible assets | 68.55M | 72.84M | 62.51M | 45.30M | 86.40M |
Short term investments | 0.31M | 0.47M | 0.47M | 0.51M | 9.56M |
Net receivables | 33.55M | 26.98M | 19.85M | 9.58M | 15.67M |
Long term debt | 40.32M | - | - | 0.24M | 0.40M |
Inventory | 11.19M | 1.30M | 2.63M | 4.74M | 8.21M |
Accounts payable | 11.65M | 16.39M | 8.84M | 7.87M | 3.62M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | -4.27000M | -4.04575M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 217.20M | 217.20M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | - | - | - | - | 5.72M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 50.78M | 42.13M | 17.15M | 8.48M | 5.72M |
Capital lease obligations | 2.90M | 5.30M | 6.19M | 6.42M | 0.37M |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Investments | -25.62800M | -27.85500M | 0.04M | 9.05M | -8.94300M |
Change to liabilities | 2.50M | 10.40M | 0.97M | 3.85M | -2.88100M |
Total cashflows from investing activities | -25.62800M | -27.85500M | -9.19600M | 8.02M | -9.78800M |
Net borrowings | 46.49M | -1.27100M | -1.45900M | -0.74600M | 0.68M |
Total cash from financing activities | 45.29M | 54.38M | 38.59M | -0.74600M | 56.53M |
Change to operating activities | 1.94M | -3.32200M | -0.82200M | 1.46M | -3.68300M |
Net income | -15.54800M | -25.32300M | -17.42000M | -46.71000M | -41.79494M |
Change in cash | -4.33100M | 11.36M | 9.26M | -16.67100M | 12.02M |
Begin period cash flow | 40.47M | 47.39M | 38.14M | 54.81M | 42.79M |
End period cash flow | 36.14M | 58.76M | 47.39M | 38.14M | 54.81M |
Total cash from operating activities | -25.03900M | -25.32300M | -19.64100M | -24.24600M | -34.05824M |
Issuance of capital stock | 0.00000M | 57.06M | 41.07M | 0.00000M | 58.78M |
Depreciation | 1.53M | 1.69M | 1.31M | 1.78M | 1.65M |
Other cashflows from investing activities | 0.01M | 0.01M | 0.01M | 0.01M | - |
Dividends paid | - | - | - | - | - |
Change to inventory | -10.25800M | 1.32M | 2.12M | 3.47M | -3.91100M |
Change to account receivables | -11.53100M | -7.13200M | -9.38600M | 6.09M | 4.09M |
Sale purchase of stock | - | - | - | - | - |
Other cashflows from financing activities | -25.62800M | -2.68600M | -2.48000M | -0.71600M | 0.77M |
Change to netincome | 3.89M | 9.48M | -2.22100M | 4.37M | 10.90M |
Capital expenditures | 25.64M | 27.86M | 9.24M | 1.06M | 0.84M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | - | - | - | - | - |
Stock based compensation | - | - | - | - | - |
Other non cash items | - | 25.32M | 17.42M | 46.71M | 41.79M |
Free cash flow | -50.68000M | -53.17800M | -28.88200M | -25.30700M | -34.90249M |
Sector: Technology Industry: Software - Infrastructure
Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
SEE Seeing Machines Limited |
- -% | 4.65 | - | - | 4.11 | 4.03 | 3.76 | -16.706 |
BYIT Bytes Technology Ltd |
-0.4 0.09% | 422.40 | 33.61 | 55.87 | 7.25 | 24.03 | 6.97 | 23.42 |
SPT Spirent Communications plc |
1.00 0.57% | 177.70 | 13.54 | 16.89 | 1.26 | 2.39 | 0.98 | 4.30 |
WPS WAG Payment Solutions PLC |
0.80 1.01% | 80.00 | 44.60 | 9.86 | 0.27 | 2.13 | 0.39 | 11.01 |
BOKU Boku Inc |
0.27 0.15% | 182.27 | 138.00 | 30.30 | 5.76 | 4.17 | 4.63 | 35.93 |
Seeing Machines Limited, together with its subsidiaries, provides driver and occupant monitoring system technologies in Australia, North America, the Asia Pacific, Europe, and internationally. It operates through two segments: Original Equipment Manufacturer (OEM) and Aftermarket. The company offers operator monitoring and intervention sensing technologies and services for the automotive, mining, transport, and aviation industries. It develops, sells, and licenses products, services, and technology to detect and manage driver fatigue and distraction, as well as provides software, after-sales monitoring, and consulting services. Seeing Machines Limited was incorporated in 2000 and is based in Fyshwick, Australia.
300 Park Avenue, New York, NY, United States, 10022
Name | Title | Year Born |
---|---|---|
Dr. Raj Mehra J.D., Ph.D. | Founder, Chairman, CEO & Pres | 1960 |
Mr. Michael J. Golembiewski | Chief Financial Officer | 1972 |
Ms. Kimberly Farrand | Sr. Director of Clinical Devel. & Operations | NA |
Mr. Anthony Marciano | Chief Communications Officer | NA |
Gopal Krishna Ph.D. | Head of Manufacturing & Technical Operations | NA |
Tim Whitaker M.D. | Chief Medical Officer | NA |
Ms. Karen Fusaro | Sr. VP & Head of Clinical Operations | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.